Mississippi lawmakers should reconsider language in a proposed Bill that could raise drug prices for consumers, the FTC’s Office of Policy Planning and Bureaus of Competition and Economics have suggested....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: